This website will offer limited functionality in this browser. We only support the recent versions of major browsers like Chrome, Firefox, Safari, and Edge.
Dr.Gregory K. Bell is quoted in this article published by BioPharm International about the regulatory and legal issues associated with bringing recent biosimilars and biobetters to market. Click below to read the article.
Group Vice President and Life Sciences Practice Leader
Boston
+1-617-425-3357 gbell@crai.comIn recent years, the adoption of advanced treatments in inflammatory bowel disease has evolved. Oral products have captured a significant share in ulcerative...
The study examines the global policy landscape for invasive fungal infections, identifies key policy gaps, and underscores the need for stronger policy...
CRA is a proud sponsor of the largest annual gathering of Medical Affairs professionals, globally. Ayushman Ghosh and Brooke Bonet present the roundtable...
CRA is a proud sponsor of Paris Arbitration Week, an international and dynamic event, involving practitioners from all over the world. For more information on...
